SCHEMBL7369595

SCHEMBL7369595

CC(C)C(=O)Oc1cc(-c2nc3ccccc3n(C)c2=O)cc([N+](=O)[O-])c1OC(=O)C(C)C

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.46
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 1/20 0.46
GAA P10253 1/20 0.46
RXFP1 Q9HBX9 3/20 0.42
CFTR P13569 5/20 0.40
HTT P42858 2/20 0.39
MAPT P10636 5/20 0.38
HSD11B1 P28845 1/20 0.38
PKM P14618 2/20 0.38
RAB9A P51151 2/20 0.38
TP53 P04637 1/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
MGAM O43451 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7367777 0.78 MAPT (0.54) HPGDALDH1A1KDM4EGAAHTT
SCHEMBL7371972 0.76 ALDH1A1 (0.55) HPGDALDH1A1KDM4EGAARXFP1
SCHEMBL8728241 0.75 POLB (0.40) ALDH1A1MAPTRAB9ATP53
SCHEMBL7367916 0.73 MMP2 (0.40) HPGDALDH1A1KDM4EGAAMAPT
SCHEMBL8733159 0.70 ALDH1A1 (0.35) ALDH1A1RXFP1MAPTRAB9ATP53
SCHEMBL8726194 0.70 PIK3CA (0.43) HPGDALDH1A1KDM4EHTTMAPT
SCHEMBL29497994 0.69 CFTR (0.73) HPGDALDH1A1KDM4EGAARXFP1
SCHEMBL19032814 0.69 CFTR (0.73) HPGDALDH1A1KDM4EGAARXFP1
SCHEMBL8733137 0.69 MAPT (0.40) ALDH1A1GAAHTTMAPTRAB9A
SCHEMBL7370121 0.68 MAPT (0.43) HPGDALDH1A1GAAHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed